Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Volvo Cars Q1 Results: Stable start to 2023, as company continues delivering on ongoing transformation with improved earnings

· Q1 revenue was SEK 95.7 bn (SEK 74.3 bn  in Q1 2022) · Q1 operating income was SEK 5.1 bn  (SEK 6.0 bn in Q1 2022) · Q1 operating income (excluding JVs and associates) was SEK 6.3 bn (SEK 5.9 bn in Q1 2022) · Q1 EBIT margin was 5.3 per cent (8.1 per cent in Q1 2022) · Q1 EBIT margin (excluding JVs and associates) was 6.6 per cent (7.9 per cent in Q1 2022) · Q1 basic earnings per share was SEK 1.21 (SEK 1.29 in Q1 2022) · Q1 fully electric car sales share at 18 per cent (8 per cent in Q1 2022)   Volvo Cars today reports a 7 per cent increase in operating profits,

Sedana Medical AB’s Interim report January-March 2023

Back to growthFirst quarter 2023 · Net sales for the quarter totalled MSEK 37.8 (33.7), equivalent to an increase of 12% compared to 2022. At constant exchange rates, sales increased by 5%. · Gross profit was MSEK 27.5 (23.0) equivalent to a margin of 73% (68%). · Earnings before interest, taxes, depreciation and amortisation (EBITDA) totalled MSEK -10.7 (-16.4), equivalent to an EBITDA margin of -28% (-49%). · Operating income (EBIT) totalled MSEK -16.3 (-22.1), equivalent to an EBIT margin of -43% (-66%). · Net income for the quarter was MSEK -16.1 (-19.0) and earnings

Interim report for the quarter ending 31 March 2023

Financial Highlights · ARR at the end of Q3 (the quarter ending 31 March 2023) was SEK 92.8m, corresponding to a 25.4% increase compared with the same period last year (SEK 74.0m). · TCV at the end of Q3 of SEK 145.1m, corresponding to a 35.9% increase compared with the same period last year (SEK 106.8m). Organic TCV growth in Q3 was 35.9% compared to the same period last year. · Net sales in Q3 were SEK 27.0m, corresponding to a 22.2% increase compared with the same period last year (SEK 22.1m). Organic net sales growth was 22.2%. · Gross profit in Q3 was SEK 25.8m (SEK 21.3m)

QFR: Final year-end financial statements for 2022 approved by the Board of Directors

26 April 2023, the Board of Directors of Q-Free ASA has reviewed and approved the final year-end financial statements for 2022. Final figures are not altered from preliminary figures published on 15 February 2023. The Annual report for 2022, including the Board of Directors report and the Consolidated Financial Statements and notes including ESEF format for 2022, will be published on the Company's website www.q-free.com together with the notice for the Annual General Meeting 2023. For further information, please contact:President & CEO, Thale Kuvås Solberg: +47 936 80 030CFO,

Ratos AB: Adjusted EBITA up 28% in the first quarter – sales growth remains favourable

Q1 2023 · Adjusted EBITA amounted to SEK 324m (253) · Operating profit amounted to SEK 285m (5) · Profit in the year-earlier period was negatively impacted by an unrealised loss of SEK -100m related to the revaluation of shares in Dun & Bradstreet Holding Inc and restructuring costs of SEK -130m attributable to Diab · Diluted earnings per share amounted to SEK -0.09 (-0.66) · Cash flow from operating activities amounted to SEK 507m (-379) · Leverage excluding finance leases was 2.2x (0.9x) Significant events during and after the end of the quarter · HL Display,

First quarter 2023 financial results

Zalaris ASA (Zalaris, OSE:ZAL) reported record-high revenues in the first quarter of 2023 of NOK 260.1 million, up 25 percent from the same period in 2022, reflecting strong underlying fundamentals."The company grew more than 25 percent in the quarter, and 17 percent in constant currency, and delivered the fifth consecutive quarter with all time high revenues. We closed the quarter with all-time-high volume of new signings in Managed Services that in total generated around 75% of our sales target for the year, and we are well on track to deliver on our target of generating NOK 1 billion in

Swedbank’s Interim report for the first quarter 2023

Swedbank´s President and CEO Jens Henriksson comments: ”Swedbank stands strong with good credit quality, strong liquidity and solid capitalisation”.   · Stronger result – all income lines increased · Net interest income increased – deposit margins rose while mortgage margins fell · Good credit quality in a turbulent quarter · Strong liquidity – large reserves with central banks · Solid capitalisation – dividend of SEK 9.75 per share approved · Index and goal for financial health – Swedbank is investing in financial literacy and comfort by offering practical advice

First-quarter results 2023

Nordea Bank AbpInterim report (Q1 and Q3)27 April 2023 at 7:30 EET Summary of the quarter Strong profitability in a slower market. The increases in interest rates and weaker economic activity continued in the first quarter. Nevertheless, Nordea’s income growth continued to drive higher operating profit, which increased by 34%, year on year, to EUR 1,480m, despite substantial depreciations of the Swedish and Norwegian currencies. Total income increased by 19%, mainly driven by growth in net interest income. Net interest margins improved, supported by deposit income. Net commission

Can AI take over everything?

No, according to researchers, AI lacks empathy and genuine emotions. A 2019 study predicted that when AI is here, EQ will go from "nice to have" to "must-have". Investing in EQ has been shown to provide up to 440% ROI in 3 years, i.e. 64% calculated on an annual basis*. Do not underestimate the power of emotions. There is no doubt that companies and organizations become more successful by measuring and developing emotional intelligence (EQ) among their leaders and employees. The World Economic Forum lists EQ as one of the most important and in-demand competencies companies

Ammonia and Hydrogen Value Chains Explored in ABS Seminar

Next Steps in Decarbonization Examined by Shipowners and Operators (SINGAPORE) Leaders from the maritime industry gathered during Singapore Maritime Week to provide their perspectives and insights on the potential of ammonia and hydrogen as marine fuels. Panelists from Singapore’s Maritime and Port Authority, Eaglestar Marine Holdings, SDTR Marine, Hafnia and Angelicoussis Group joined ABS for a robust discussion on the practical issues now trending in maritime decarbonization. “ABS remains committed to supporting the safe adoption of alternatives fuels and today’s event is

AFRICA OIL ANNUAL GENERAL MEETING TO BE HELD ON MAY 25, 2023

VANCOUVER, BC, April 26, 2023 /CNW/ - (TSX – AOI, Nasdaq Stockholm - AOI) - Africa Oil Corp. (“Africa Oil” or the “Company”) announces that its Annual General Meeting of Shareholders will be held on Thursday, May 25, 2023 at 10:00 am (Pacific Time) at Suite 2000, 885 West Georgia Street Vancouver, BC, V6C 3E8. The purpose of the Meeting is as follows: 1. To receive the consolidated audited financial statements and accompanying management’s discussion and analysis of the Company for the year ended December 31, 2022, together with the report of the auditors; 2. To appoint

Quickbit publishes Q3 interim report ‘22/23

Quickbit reports sales of € 59.3 million in Q3 ’22/23, where sales in the upper part of the preliminary range announced. The gross margin for the quarter was 4.2%. The preconditions are in place for Quickbit to once again increase transaction volumes, lower its cost base and thereby generate profitable growth.Third quarter, January - March 2023 in summary · Net sales totalled € 59.3 million (92.1). · Gross profit amounted to € 2.5 million (3.7) with a gross margin of 4.2% (4.0%). · Adjusted EBITDA was € 0.0 million (1.1). · EBIT totalled € -3.8 million (0.2). · Basic

Calliditas Therapeutics’ 2022 Annual Report Published

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) today announces that the Annual Report for 2022 now is available at the company’s website: www.calliditas.com For further information, please contact: Åsa Hillsten, Head of Investor Relations, Calliditas Therapeutics AB Phone: +46 764 03 35 43 E-mail: asa.hillsten@calliditas.com This information is information that Calliditas Therapeutics AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 21:00 CET on April 26, 2023. About Calliditas

RaySearch publishes preliminary results for the first quarter of 2023

RaySearch Laboratories AB (publ) publishes preliminary figures for the first quarter of 2023. Preliminary net sales increase by 10 percent to SEK 230 (208) million, preliminary EBIT amounts to SEK 24 (30) million and order intake amounts to SEK 207 (273) million. RaySearch’s report for the first quarter will be published on May 17.The preliminary figures mean that as of March 31, 2023, RaySearch does not meet a solidity- and an EBITDA-based covenant related to the company's credit facility with Skandinaviska Enskilda Banken (publ). The total credit facility amounts to SEK 200 million, of

Vår Energi ASA announces pricing of inaugural Euro Senior Notes Offering

Sandnes, Norway, 26 April 2023: Vår Energi ASA (OSE: VAR, the "Company") is pleased to announce that it has priced an offering of EUR 600 million Senior Notes under Vår Energi ASA’s recently established Euro Medium Term Note programme. The Notes mature in May 2029 and carry an annual fixed coupon of 5.5% at a price equal to 99.696% of the aggregate principal amount thereof. The Notes will be listed on the regulated market of the Luxembourg Stock Exchange. The Company intends to use the net proceeds of the Offering for a partial refinancing of the Company’s bridge-to-bond facility

BioGaia’s results for the first quarter to exceed market expectations

(Figures in the brackets refer to the same period the previous year) During the first quarter of 2023, BioGaia's sales have been impacted by increased demand, mainly in the Americas and APAC. The sales in Americas have also been positively impacted by certain one-time effects related to BioGaia starting to sell through its own subsidiary, BioGaia Canada. The sales in APAC have been positively impacted by effects related to the removal of covid restrictions in China. For the first quarter, sales are preliminarily estimated at SEK 366 million (284), an increase of 29% (excluding foreign

NYAB Plc: Organizing of the Board of Directors

NYAB PlcCOMPANY ANNOUNCEMENT26 April 2023 at 19:50NYAB Plc: Organizing of the Board of Directors NYAB Plc’s Board of Directors, that was elected by today’s Annual General Meeting, has elected Markku Kankaala as Chairman of the Board and Jan Öhman as Vice Chairman of the Board in its organizing meeting. Board of Directors has made the following assessment of independence of its members: · Jari Suominen, Lars-Eric Aaro, Anders Berg, Barbro Frisch and Jan Öhman are independent of the company and its major shareholders · Markku Kankaala is not independent of the major

Notice of annual general meeting in Truecaller AB

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders in Truecaller AB, Reg. No. 559278-2774, are hereby invited to attend the annual general meeting (Sw. årsstämma) to be held at the company’s premises at Mäster Samuelsgatan 56 in Stockholm, Sweden, on Friday 26 May 2023 at 2 p.m. Right to participate in the meeting and notice of participation Shareholders wishing to attend the annual general meeting must: ●         be registered in the company’s share

Bulletin from the Annual General Meeting on April 26, 2023 in Electrolux Professional AB (publ)

Electrolux Professional's Annual General Meeting was held on April 26, 2023. The shareholders were also able to exercise their voting rights by postal voting in accordance with the provisions of Electrolux Professional’s Articles of Association.Income statements and balance sheets, dispositions in respect of the Company’s profit in accordance with the adopted balance sheet and discharge of liability The parent company’s and the Group’s income statements, and balance sheets were adopted. The Annual General Meeting resolved on a dividend of SEK 0.70 per share and that the retained earnings

Henning Olsen is leaving NRC Group

Today, Henning Olsen, CEO of NRC Group, submitted his notice of resignation. He has accepted to start as CEO at Eidsiva Energi AS, the largest regional energy and telecom company in Norway. “Henning has been with the company the past four years and has played an important role to develop and transform NRC Group. We are thankful for his significant contributions over his tenure. Henning has built a robust organisation across the countries, and has implemented significant operational and financial improvements”, says Rolf Jansson, Chair of the Board of Directors of NRC Group. The Board

Director Declaration

26 April 2023 16:45 BST Director Declaration AstraZeneca PLC (the Company) today announced that Aradhana Sarin, Chief Financial Officer and Executive Director of the Company, has been appointed as an independent director of Anheuser-Busch InBev with effect from 26 April 2023, for a period of four years. This announcement is made pursuant to Listing Rule 9.6.14 R (2). AstraZenecaAstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare

Wihlborgs Fastigheter AB (publ) AGM 2023

At Wihlborgs Fastigheter AB’s AGM on 26 April 2023, the meeting agreed to the Board’s proposal for a dividend for 2022 of SEK 3.10 per share. The record date for receiving the dividend was set at Friday, 28 April 2023. Cash payment will be sent by Euroclear Sweden AB on Thursday 4 May 2023. The Board of Directors and the CEO were granted freedom of responsibility for the year 2022. The AGM agreed that the Board be authorized until no later than the next Annual General Meeting to acquire and assign own shares. An acquisition shall not exceed the number of shares which from time to time

There are no items matching the current filter
There are no more items matching the current filter
Back to top